• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART COATED AORTIC VALVED GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART COATED AORTIC VALVED GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 27CAVGJ-514 00
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Brain Injury (2219); Respiratory Insufficiency (4462); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/25/2022
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that on (b)(6) 2022, a 27mm masters aortic valved graft was successfully implanted.There were no intraprocedural adverse events.On (b)(6) 2022, patient's c-reactive protein was 237.3 mg/l.On (b)(6) 2022, the patient had a severe ischemic stroke with mrs score of 5.The patient was unconscious with no noticeable reaction to stimuli and no reflexes.The patient had left-sided paresis.A computed tomography (ct) scan revealed acute ischemic changes and a swelling of almost the entire right hemisphere of the brain.The patient was intubated and placed on mechanical ventilation.Medications including antibiotics, antifungal, narcotics, diuretics, sedatives, beta blockers, and anticoagulants were administered.On (b)(6) 2022, the patient was discharged from the implant site hospital and transferred to another hospital.The patient's symptoms were ongoing at time of transfer.There were no device deficiencies reported.No additional information was provided.
 
Manufacturer Narrative
An event of ischemic stroke five days after the implant procedure was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.H6 health effect - clinical code 4581 removed and 2219 added.
 
Manufacturer Narrative
An event of ischemic stroke five days after the valve implant procedure and patient death about one month after the implant procedure was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.H6.Health effect - clinical code : removed code 4581 appropriate term / code not available.
 
Event Description
It was reported that on (b)(6) 2022, a 27mm masters aortic valved graft was successfully implanted.There were no intraprocedural adverse events.On (b)(6) 2022, patient's c-reactive protein was 237.3 mg/l.On (b)(6) 2022, the patient had a severe ischemic stroke with mrs score of 5.The patient was unconscious with no noticeable reaction to stimuli and no reflexes.The patient had left-sided paresis.A computed tomography (ct) scan revealed acute ischemic changes and a swelling of almost the entire right hemisphere of the brain.The patient was intubated and placed on mechanical ventilation.Medications including antibiotics, antifungal, narcotics, diuretics, sedatives, beta blockers, and anticoagulants were administered.On (b)(6) 2022, the patient was discharged from the implant site hospital and transferred to another hospital.The patient's symptoms were ongoing at time of transfer.There were no device deficiencies reported.Subsequent to the previously filed report, additional information was received that the patient died on (b)(6) 2022 in the intensive care unit.
 
Manufacturer Narrative
An event of ischemic stroke five days after the valve implant procedure and patient death about one month after the implant procedure was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The exact cause of death was unknown but was likely related to the ischemic stroke and patients clinical condition.It was unknown if the stroke was procedure or device related.Based on the information received, the cause of the reported incident could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART COATED AORTIC VALVED GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key14217124
MDR Text Key290143822
Report Number2135147-2022-00226
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734006422
UDI-Public05414734006422
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 09/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/27/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number27CAVGJ-514 00
Device Catalogue Number27CAVGJ-514 00
Device Lot Number8266191
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Disability; Death; Hospitalization;
Patient Age41 YR
Patient SexMale
Patient Weight105 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-